Estrogen And Progesterone Receptors In Dysfunctional Uterine Bleeding

Decreased expression of survivin, estrogen and progesterone receptors in endometrial tissues after radiofrequency treatment of dysfunctional uterine bleeding

BACKGROUND The purpose of the research is to study the histopathology and expression of survivin, estrogen and progesterone receptors (ER/PR) in the endometrium of patients with dysfunctional uterine bleeding (DUB) treated with radiofrequency endometrial ablation (REA). METHODS A total of 98 DUB patients were enrolled in this case-control study. Among them, 66 underwent REA treatment and 32 o...

Expression of Estrogen and Progesterone Receptors in Papillary Thyroid Carcinoma

Background: Papillary thyroid carcinoma (PTC), occurs mostly in women and sex hormones may play a role in the pathogenesis and clinical course. The objective of this study was to determine the status and prevalence of estrogen and progesterone receptors in PTC with regard to age, gender, tumor size and lymph node involvement. Methods: Immunohistochemical stains were performed on 92 tissue bl...

Clinco-Pathological Patterns in Women with Dysfunctional Uterine Bleeding

Background: The term dysfunctional uterine bleeding(DUB) refers to any abnormal bleeding from the uterus, unassociated with tumour, inflammation and pregnancy. The histological diagnosis of DUB is very essential for adequate management especially in perimenopausal and postmenopausal females. The present study was undertaken with the aim of evaluating DUB in various age groups, carry out histopa...

Thyroid Dysfunction in Dysfunctional Uterine Bleeding

Abnormal uterine bleeding is a frequent debilitating symptom resulting in unnecessary, incorrect and expensive treatment and invariably ends up in surgical treatment with its attendant risk of morbidity and mortality. It occurs in 9-14% of women between menarche and menopause, significantly impacting quality of life and imposing financial burden (3). After excluding the structural causes of AUB...

The management of dysfunctional uterine bleeding.